News

transmission towers
How artificial intelligence can transform US energy infrastructure
Surprisingly, changing isotope masses of molybdenum in a single layer of semiconductor molybdenum disulfide was found to shift the color of light emitted when the layer was illuminated. The study revealed the potential of isotope engineering to design new technologies in 2D materials. Credit: Chris Rouleau/ORNL, U.S. Dept. of Energy
Tweaking isotopes sheds light on semiconductors
The Linac Coherent Light Source at DOE’s SLAC National Accelerator Laboratory in California reveals the structural dynamics of atoms and molecules through X-ray snapshots at ultrafast timescales. Pictured here is the LCLS-II tunnel. Credit: Jim Gensheimer/SLAC National Accelerator Laboratory
ORNL, SLAC team up for biology projects

Filter News

Area of Research

News Type

Date

News Topics

Media Contacts

Connect with ORNL

ORNL’s RapidCure improves lithium-ion electrode production by producing electrodes faster, reducing the energy necessary for manufacturing and eliminating the need for a solvent recycling unit. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Seven ORNL technologies win R&D 100 research awards

Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy

DOE scientists deploy creativity, speed to disrupt COVID-19

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.